Glenzocimab

Glenzocimab (ACT017) is a Fab fragment of humanized anti-GPVI monoclonal antibody. Glenzocimab inhibits collagen-induced platelet aggregation. Glenzocimab has the potential for the research of acute ischemic stroke.
Read more
€0.00 (tax incl.)
Reference:
HY-P99644
Product Details
HY-P99644

Data sheet

Size
Multiple sizes
Reactivity
Others
CAS
2101829-58-5

Menu

Settings